The Lung Cancer Research Foundation (LCRF) and Carebox have announced the launch of a Carebox Connect experience optimized for lung cancer patients.
From the clinical trials page of the LCRF website, lung cancer patients, their caregivers, and healthcare professionals can visit the Carebox Connect web application to search for and match to potentially relevant trials. By making this search resource available on its website, LCRF is connecting patients to research and enabling them to make the best treatment decisions for themselves.
Visitors to the web application can complete a ten-question questionnaire about the patient's lung cancer condition and then see which actively recruiting clinical trials with treatment options, are potentially relevant for them. They can then get connected to a trial research site for next steps.
The Carebox Connect trial database is synchronized daily with the ClinicalTrials.gov clinical trial data maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). Applying its human-supervised AI, Carebox converts the unstructured text in ClinicalTrials.gov that describes eligibility criteria for enrollment, into a searchable index of clinical criteria for matching with patient characteristics.
For more advanced users, full search and filtering capabilities are available. Filters can be saved for future use. Furthermore, based on those saved filters, users can subscribe to receive Carebox Connect notifications in their email inbox whenever new trials open (or new sites open) in a defined distance radius from where they are located.
"LCRF is on a mission to improve lung cancer outcomes by funding research for prevention, diagnosis, treatment, and cure. Patient participation in clinical trials is a critical component on the road to our vision of a world free of lung cancer", explains Aubrey Rhodes, Executive Director of LCRF, adding that "Carebox Connect enables us to both advance research and make clinical trial treatment options much more accessible to the lung cancer patient community."
"The Carebox Connect Network has a common technology foundation and a unified end-user application," notes Assaf Levi, Carebox VP of R&D. "However, we can create customized experiences for each specific condition so that lung cancer patients arriving from LCRF are directed to the relevant questionnaire and trials for them. Knowing that we are touching the lives of so many patients and can help support efforts of organizations like LCRF in advancing such important research, is core to what makes working at Carebox special for the entire engineering team."
Lung Cancer Research Foundation (LCRF) Joins Carebox Connect Network. (2023, August 1). Cision PR Newswire.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.